“If we strengthen the research ecosystem with the right infrastructure, we’ll bring more trials to Australia, and brain cancer patients will have access to potential new treatments—and that’s hope.”
Josie Downey
General Manager and Managing Director, Merck Healthcare, Australia and New Zealand
Josie Downey joins Brain Cancer Australia Board.
Brain Cancer Australia is delighted to welcome Josie Downey, General Manager and Managing Director, Merck Healthcare Australia and New Zealand, to its Board of Directors.
Josie brings more than 20 years of experience in the pharmaceutical and biotechnology sectors - and a personal drive to accelerate progress in brain cancer, after losing her sister-in-law, Julie, to the disease in 2019.
“What really stood out to me about Brain Cancer Australia was the clarity of the strategy—the alignment of research, patient care, data and infrastructure—and the calibre of the people involved. The approach is patient-focused, it’s collaborative, and it’s built to deliver real impact. I can’t wait to get started.”
Josie’s career began as a junior research scientist and evolved into senior leadership roles at global companies including MSD and Merck, and as a board member of Medicines Australia. She’s led large-scale commercial operations, launched a breakthrough immunotherapy, and worked across every stage of drug development.
Now, Josie is drawing on her experience and expertise to support the execution of three national research infrastructure platforms.
Josie was impressed by Brain Cancer Australia’s focus on systematising what matters. “If we can simplify how data and tissue are collected and used, we reduce cost, increase efficiency, and speed up research,” she says. “And by strengthening our research ecosystem with the right infrastructure, we can attract global trials and give patients faster access to potential new treatments—and that’s hope.”
Josie also sees a strong case for greater investment. “Brain cancer often affects people in their most productive years. The ripple effects on families and workplaces are significant. There are compelling reasons for the government to invest more in research infrastructure - it’s not just about saving lives; it’s about addressing a wider economic and societal impact.”
Brain Cancer Australia Founding Director Robyn Leonard is thrilled to welcome Josie to the Board. “She brings not just a wealth of experience but a deep understanding of what’s at stake. Her leadership will be vital as we build the infrastructure needed to transform outcomes for people with brain cancer.”
